Investor relations

Board of Directors

Kenneth (Ken) Lever

Non-Executive Chair

Length of tenure

Appointed 22 March 2023 (Executive Chair from 5 April 2023 to 10 May 2023, Interim Chair until 15 February 2024)

Skills and experience

Ken is an experienced business leader, having held a number of senior executive and non- executive positions within UK-listed firms.

He is currently Senior Independent Director and Chairman of the Audit Committee at both Vertu Motors plc and Rockwood Strategic plc, as well as Deputy Chairman of Rainier Developments Limited. Ken has recently stepped down as Non-executive Chairman of Biffa plc and RPS Group plc.

Ken was also a Non-executive Director at Blue Prism plc, an intelligent automation software business, where he was Chair of the Audit Committee.

In his executive career, Ken was latterly Chief Executive Officer of technology, business services and insurance software business Xchanging plc.

Ken is Chair of the Advisory Board of the Alliance Manchester Business School and was a member of the Accounting Council (formally the Accounting Standards Board) of the Financial Reporting Council.

External appointments

Ken is the Senior Independent Director and Chairman of the Audit Committee of Vertu Motors plc, the Senior Independent Director and Chairman of the Audit Committee of Rockwood Strategic plc and Deputy Chairman of Rainier Developments Limited.

Chris Baker

Non-Executive Director

Length of tenure

Appointed 25 July 2023

Skills and experience

Chris Baker is an experienced leader in the international technology industry and currently a partner of CBCS Associates, a software advisory business. From 1983 to 1997 Chris was with Digital Equipment Company, rising to serve as UK Sales Director for Outsourcing. During the period 1997 to 2014, Chris held several senior roles within Oracle, rising to Senior Vice President and Worldwide Head of ISV/OEM/Java Sales. Chris was then Executive Director of Xchanging plc from 2014 to 2016, leading the Xuber Insurance Software business, and from 2016 to 2021 Chris was CEO of Capita Software.

External appointments

Partner of CBCS Associates.

Amanda Jobbins

Non-Executive Director

Amanda Jobbins is internationally renowned technology industry executive having led global business development, sales and marketing organizations for major SaaS, Comms & IT enterprise software companies in the USA, Europe & Asia. Amanda is currently the Global CMO & Director of GTM & Strategic Partners of Vodafone Business, the enterprise division of Vodafone serving orgranizations worldwide with security, cloud and digital solutions.

Amanda has extensive experience leading technology organizations and was formerly Global CMO of Infor and an SVP at Oracle leading their global business development and international marketing organisations across all product lines. Over her career she also led significant organizations at Cisco and Symantec, where she led strategy, product marketing and the consumer GTM as well as running channel sales teams. Amanda was previously on the board of ISG Plc, an AIM listed company & StorMagic Plc a UK based network attached storage small cap.

Amanda is also currently on the board of PairPoint , an IOT economy of things JV between Vodafone and Sumitomo & is on the Hull University MBA Advisory Board.

Amanda has been recognized as a FTSE Women to Watch by Cranfield Business School and with experience managing operations for organizations with revenues of $40B+ as well as entrepreneurial experience & mind-set gained at mid & small-cap growth companies. We’re delighted Amanda is joining the board of Cirata.

Eric Collins

Non-Executive Director

Eric Collins is an investor, serial entrepreneur, technology executive and award winning author.

Eric has been in the C suite of 4 fast growth companies that exited to American listed companies including Microsoft, Medtronic and Digital Turbine. 2 companies were in the US and 2 were in the UK.

In 2018, Eric co-founded Impact X Capital Partners with a group of distinguished UK, French and US investors. In 2023, Impact X launched its second fund to invest in underrepresented entrepreneurs in Europe, the UK, the US and beyond. Impact X has over 50 investments in its portfolio including the UK insurtech unicorn Marshmallow. Eric is the CEO of Impact X and sits on the boards of private companies in the US and the UK.

Eric has been featured in Bloomberg, CNN, Dow Jones, The Times, The Guardian, BBC Radio, ITV News, Sky News, and numerous other media outlets and podcasts.

He is regularly invited to be a keynote speaker or panellist for leading companies and events both in the UK and internationally. Recently he has spoken for Morgan Stanley; Goldman Sachs; Google; JP Morgan; Bank of America; Paramount; Aviva, US Embassy London; London & Partners; Latham & Watkins; Europe’s largest business show, The Business Show; the private markets conference IPEM; Gitex Dubai; the global tech festival, London Tech Week; the world’s leading content development marketplace, Content London; and Asia's leading entertainment content market and conference, Asia TV Forum & Market. He has also been featured as a writer at the Oxford Book Festival as well as the Black British Book Festival. In his award-winning book, We Don’t Need Permission: How Black Business Can Change Our World (Penguin), Eric argues investing in Black and underrepresented entrepreneurs is the surest, fastest socio-economic game changer there is.

Civically, Eric serves on the board of UnLtd foundation, the leading provider of support to social entrepreneurs in and around the UK. He is a board member of Autograph ABP, the UK’s leading gallery dedicated to championing the work of artists who use photography and film to highlight questions of race, representation, human rights and social justice. He co-led the Contested Heritage Committee of Southwark Cathedral and is an Executive Producer for Philomela’s Chorus - the UK initiative which underwrites the making of short films by artists who identify as Black women.

Eric is also a brand ambassador for luxury car manufacturer, Audi, the youth charity The Prince’s Trust, and is affiliated with the Dorchester Collection’s Legend Series.

Stephen Kelly

Executive Director, CEO

Length of tenure

Appointed 10 May 2023

Skills and experience

Stephen Kelly is a successful, serial growth CEO with global experience in complex enterprise software and technology businesses channels. Stephen has an exceptional leadership record from start- ups to the largest organisations in both private and public sectors. Stephen led the turnarounds as CEO of Sage (FTSE50), Micro Focus (FTSE250), and grew Chordiant rapidly (Nasdaq) adding approximately $10bn of market value increase over almost 50 quarters during his stewardship as a public company CEO. The companies led by Stephen all became global market leaders in their sectors.

In the 1980s, Stephen joined the early-stage European team at Oracle where annual triple-digit revenue growth was the standard in the enterprise data business. Stephen was appointed the UK government’s first Chief Operating Officer during the Coalition government, where Efficiency & Reform programs delivered £50bn annual savings as well as major innovations including the delivery of Gov.UK and the digitisation of UK government which was awarded “UN best digital government” in 2016.

External appointments

Chair Science, Technology & Research Honours Committee (sits on main Honours Committee).

Member of No 10 Downing Street Digital Fellows Board.

Senior Adviser to Blackrock (LTPC).

NED Locum’s Nest (Healthtech).

Board Committees

The company has established an Audit and Risk Committee, a Nomination committee and a Remuneration Committee with formally delegated duties and responsibilities and with written terms of reference. Each of these committees meet regularly. From time to time, separate committees will be set up by the board to consider specific issues.

Audit and Risk Committee

Amongst other responsibilities, the Audit and Risk Committee is responsible for monitoring and ensuring the truth and fairness of the Company’s financial statements before submission to the Board for approval, ensuring compliance with appropriate accounting standards, the law and the AIM Rules. The Audit and Risk Committee meets twice a year and often interacts with the external auditor.

Nomination Committee

The Nomination Committee is responsible for reviewing the structure, size and composition of the Board and recommending any changes required, succession planning and identifying and nominating board candidates for vacancies as and when they arise. The Committee is also responsible for reviewing the results of any Board performance evaluation process. The Nomination Committee meets at least twice a year.

Remuneration Committee

The Remuneration Committee’s primary purpose is to assist the Board in determining the Company’s remuneration policies, reviewing the performance of Executive Directors and make recommendations to the Board on matters relating to their remuneration and terms of service.

Board appointment and re-election

Directors are subject to re-election at the Annual General Meeting (“AGM”) following their appointment. In addition, at each AGM one-third (or the whole number nearest to one-third) of the Directors retire by rotation.

Terms of appointment and time commitment

All Non-executive Directors are appointed for an initial term of three years subject to satisfactory performance. After this time, they may serve additional three-year terms following review by the Board. All Non-executive Directors are expected to devote such time as is necessary for the proper performance of their duties. Directors are expected to attend all Board meetings and Committee meetings of which they are members and any additional meetings as required. Further details of their terms and conditions are summarized in the Remuneration report on pages 43 to 45 of the annual report and the terms and conditions of appointment of the Non-executive Directors are available at the Company’s registered office.

Communicating to our shareholders

The AGM is the principal forum for dialogue with private shareholders, and we encourage shareholders to attend and participate. The last AGM was held on Tuesday 14 May 2024 at Brown Rudnick’s London office, with the results being published on our website, www.cirata.com/investors.

Next year’s AGM is expected to be held at 2:00pm on 23 April 2025 at Brown Rudnick’s London office. Full details will be included in the Notice of Meeting, which is sent to shareholders at least 21 days before the meeting.

DISCLAIMER – IMPORTANT

ELECTRONIC VERSIONS OF THE INFORMATION AND MATERIALS YOU ARE SEEKING TO ACCESS, TO WHICH THIS GATEPOST GIVES ACCESS, ARE BEING MADE AVAILABLE ON THIS WEBSITE BY CIRATA PLC (THE “COMPANY”) IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY.

THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS LOCATED IN OR RESIDENT IN (OR ORGANISED OR INCORPORATED UNDER THE LAWS OF) THE UNITED STATES, THE COMMONWEALTH OF AUSTRALIA, ITS TERRITORIES AND POSSESSIONS, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR SWITZERLAND, OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION.

The information and materials you are seeking to access do not constitute or form a part of any offer to sell, or a solicitation of an offer to purchase or subscribe for, any securities of the Company in the United States (including any state, possession or territory) or any other jurisdiction where it is unlawful to do so. Any securities issued in connection with an offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “US Securities Act”), or under any applicable securities laws of any state, province, possession, territory, county or jurisdiction of the United States, Australia, Canada or Japan. Such securities may not be offered or sold in the United States or to, or for the account or benefit of, US persons (as defined in Regulation S under the US Securities Act) unless registered under the US Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration. Further, unless an exemption under relevant securities laws is applicable, any such securities may not be offered, sold, resold, taken up, exercised, renounced, transferred, delivered or distributed, directly or indirectly, in or into the United States, Australia, Canada, Japan, or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration of such securities in, the relevant jurisdiction. There will be no public offer of securities of the Company in the United States.

The information and materials you are seeking access to are only addressed to and directed at persons in member states of the European Economic Area (“EEA”) who are “qualified investors” within the meaning of Article 2(E) of the prospectus regulation 2017/1129 ("Prospectus Regulation") (and any amendments thereto) (“Qualified Investors”). In addition, in the United Kingdom, the materials are being distributed only to, and are directed at Qualified Investors who (a) fall within the definition of "investment professionals" within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (b) are high net worth entities, and other persons as described in Article 49(2)(a) to (d) of the Order or, otherwise to persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as “Relevant Persons”). Any investment or investment activity to which these materials relates are available only to Relevant Persons in the United Kingdom and Qualified Investors in any member state of the EEA other than the United Kingdom, and will be engaged in only with such persons.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage. These materials must not be, released or otherwise forwarded, distributed or sent to any US persons or in or into the United States, Australia, Canada, Japan, or any jurisdiction in which such offers or sales are unlawful. Persons receiving such documents (including custodians, nominees and trustees) must not distribute or send them to any US persons or in, or into the United States, Australia, Canada, Japan, or any other jurisdiction in which such offers or sales are unlawful.

Confirmation of understanding and acceptance of disclaimer

By clicking “I CONFIRM” below, you:

(i) confirm that you have read and understood the disclaimer set out above, that you understand that it may affect your rights, that you agree to be bound by its terms and that you confirm that you are permitted to proceed to this part of the website;

(ii) certify that you are not a US person (as defined in Regulation S of the US Securities Act) or a resident of or located in the United States or a person acting on behalf of the foregoing and agree that you will not retransmit, send or otherwise transfer any of the information contained on this website to any US person or person in or resident in the United States; and

(iii) warrant that you are not a resident of or located in Australia, Canada or Japan or any other jurisdiction where accessing these materials is unlawful, and you agree that you will not retransmit, send or otherwise transfer any of the information contained on this website to any person in Australia, Canada, Japan or any other jurisdiction where to do so would breach applicable local law or regulation.

PLEASE NOTE that it is your responsibility to satisfy yourself as to the full observance of any relevant laws and regulatory requirements. If you are in any doubt, you should not continue to seek access to this area of the website.

Cirata Plc does not accept any responsibility for any contravention of applicable securities laws and regulations by individuals as a result of false information provided by such individuals.

3497099 v2

I Disagree I CONFIRM

Investors Relations

Overview

Regulatory News

Reports and Presentations

Key Performance Indicators

Analyst Coverage

Share Price Information

Shareholders

Board of Directors

Corporate Governance

Key Company Advisors

AIM Rule 26

For more information

ir@cirata.com

US +1 925 380 1728

UK +44 (0) 20 3727 1000
via FTI consulting